TORICA® is a one-piece capsular bag lens for correcting astigmatism in cataracts. Due to the toric, meridional aspheric optic, the IOL allows for outstanding refractive results and thus full patient satisfaction!
Based on the premium IOL platform, TORICA® has the following advantages:
| Type | Toric posterior chamber IOL, 1-piece, foldable, optional blue light protection |
| Optic diameter | 6.0 mm |
| Total diameter | 12.5 mm |
| Material | Hydrophilic, glistening-free MicroCryl®, UV absorber |
| Optic features | Toric meridional aspheric anterior surface, aberration-free, 360° LEC barrier, HD optic |
| Haptic design | C-loop |
| Estimated A-constant (optical biometry) | 118.4 |
| XL diopter range | sph: -20.0 to 40.0 D in 0.5 D steps cyl: 1.0 to 20.0 D in 0.5 D steps Extended diopter range on request |
| Also availabe as | MC 6125 T MC 6125 T-Y YELLOW |
Our individual service
The fastest way to TORICA®
TORICA-aA/-aAY is a product with more than 20 years of know-how in development and manufacturing of toric lenses. HumanOptics is one of the world’s pioneers in this field and launched one of the first toric IOLs as early as 1997. Since then, HumanOptics has consistently developed the concept and, with the TORICA®, offers a premium IOL for precise astigmatism correction.
As a leading manufacturer of premium IOLs, HumanOptics has a high-precision manufacturing facility. This enables us to produce optical surfaces with an accuracy in the nanometer range: the optimal aspheric torus can be created with corresponding precision. High-quality meridional aspheric optics are the result of Sub-nano resolution technology.
Its meridional aspheric torus gives the TORICA® maximum imaging quality. The asphericity is specifically adapted to the radii of the toric optic. Both meridians are aberration-free – an essential advantage over the conventional correction to the mean asphericity. Patients benefit from a more point-shaped image and improved contrast sensitivity.
The XL delivery range of TORICA® allows for exact compensation of astigmatism even with high cylinder values. For special cases HumanOptics produces toric IOLs beyond standard values commonly available on the market. Even patients with extreme visual defects can significantly improve their quality of life. With their extraordinary range of products and additional individual solutions, HumanOptics accepts not only medical responsibility but also social responsibility.
The excellent efficacy and safety of TORICA® have been confirmed in clinical use.
“The postoperative results of this study demonstrate the excellent rotational stability and good postoperative predictability of the TORICA-aA/-aAY IOL, combined with easy handling and the absence of any postoperative complications.”
100% of patients would opt again for the implantation of the TORICA-aA/-aAY IOL.
Visit our online IOL Calculator MICROTRACE
This post is also available in: German
Our experts support you with your questions at any time.
News
From September 21. to September 25. 2018 the 36. congress of the European Society of Cataract and Refractive Surgeons took place in Vienna. HumanOptics AG successfully launched the new intraocular lens ASPIRA-aXA for the European market.
With ist 7.0 mm XL optic, the ASPIRA-aXA aroused great interest. The preloaded ASPIRA-aXA provides a convenient implantation of an IOL with XL optic by maintenance of the routine in the OR. For patients with increased risk of ocular diseases the ASPIRA-aXA lays the foundations for a long-term pseudophakic reliability. The posterior chamber lens with its XL optic is also an ideal treatment option for patients with large pupils.
One of HumanOptics‘ highlights was the forum Meet the Expert. Prof. Matthias Bolz (Kepler Universitätsklinikum Linz, Austria) presented results with the ASPIRA-aXA, showed areas of application and informed about relevant factors for a successful implantation.
Another popular topic was the CUSTOMFLEX® ARTIFICIALIRIS. The iris prothesis has received FDA approval recently and is at present the only product of this kind that is approved for the highly attractive U.S. market and addresses this currently unmet medical need in that market.
The bright, welcoming booth was used for conversations and consultations about the product portfolio of HumanOptics efficiently.
